GEHCV GE HEALTHCARE TECHNOLOGIES INC

GE HealthCare named to 2025 Fortune World’s Most Admired Companies™ list

CHICAGO--(BUSINESS WIRE)--

GE HealthCare (Nasdaq: GEHC) has been named to 2025 Fortune World’s Most Admired Companies™ list. The company has been recognized across several categories including the quality of management, products and services, innovation, value as a long-term investment, financial soundness, talent acquisition and retention, community and environmental responsibility, global business, and use of corporate assets.

Being named to Fortune World’s Most Admired Companies™ list for the first time, two years after becoming an independent company, is a testament to GE HealthCare’s progress against its precision care strategy across disease states, enabling colleagues to deliver innovations that improve clinical workflows and help clinicians make more precise diagnoses and improve patient outcomes.

“This recognition is a testament to the dedication of our 51,000 global colleagues who help deliver our precision care strategy to best serve our patients and customers,” said Peter Arduini, President and CEO at GE HealthCare. “Our entrepreneurial and inclusive culture ensures that the broad perspectives and expertise of our teams continue to build our 125-year legacy of innovation, advance our purpose-driven strategy and help make a meaningful impact on healthcare worldwide.”

A company's score must rank in the top half of its industry survey to be listed. The ranking is considered the “gold standard” for employee-centric companies, highlighting employers who have created an exemplary work environment. For more information and to view the complete list of companies, visit: .

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator, dedicated to providing integrated solutions, services, and data analytics to make hospitals more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected, and compassionate care, while simplifying the patient’s journey across the care pathway. Together our Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics businesses help improve patient care from diagnosis, to therapy, to monitoring. We are a $19.6 billion business with approximately 51,000 colleagues working to create a world where healthcare has no limits.

Follow us on, , , , and for the latest news, or visit our website for more information.

From Fortune, ©2025 Fortune Media IP Limited. All rights reserved. Used under license. Fortune is a registered trademark and Fortune World’s Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse the products or services of GE HealthCare.

EN
29/01/2025

Underlying

GEHCVGE HEALTHCARE TECHNOLOGIES INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on GE HEALTHCARE TECHNOLOGIES INC

 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare launches AI-driven, patient-friendly Invenia ABUS Premiu...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) announced the launch of Invenia™ Automated Breast Ultrasound (ABUS) Premium, the latest 3D ultrasound offering advanced artificial intelligence (AI) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. Approximately 71% of cancers occur in dense breasts.1 According to studies across the U.S. and Europe, 40% of women2 and 70% of Asian women3 have dense breast tissue, making them four to six times more likely to receive a breast cancer diagnosis.4 Early d...

March 20, 2025 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare and NVIDIA reimagine diagnostic imaging with autonomous ...

SAN JOSE, Calif.--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced a collaboration with NVIDIA at GTC 2025, expanding the existing relationship between the two companies to focus on pioneering innovation in autonomous imaging, beginning with autonomous X-ray technologies and autonomous applications within ultrasound. GE HealthCare has been at the forefront of medical technology innovation with a series of “firsts” that date back more than a century, starting with the invention of its X-ray tube, followed by several others including the first handheld ultrasound, first 3D obstetr...

March 18, 2025 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare expands invasive cardiology solutions portfolio with Alt...

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced the launch of the AltiX AI.i edition of Mac-Lab™, CardioLab™ and ComboLab™. The AltiX AI.i editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. These latest editions offer new features that can streamline workflow and enhance interoperability, while upholding strong cybersecurity standards. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 ...

March 17, 2025 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare Advances Its Cloud Strategy by Unveiling the Genesis Por...

LAS VEGAS--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC) today announced its new Genesis solutions, a portfolio of cloud enterprise imaging software-as-a-service (SaaS) solutions. Four features will be offered when commercially released – edge, storage, vendor neutral archive and data migration.i These cloud solutions, are designed to help enhance healthcare organizations’ efficiency and precision, streamline workflows, and optimize the use of capital and IT resources. The growing volume and complexity of patient cases are putting increasing pressure on hospitals’ IT systems, driving the ne...

March 4, 2025 1 EN
 PRESS RELEASE
Free
GEHCV GE HEALTHCARE T...

GE HealthCare names new president and CEO, China

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leading global healthcare solutions provider, today announced that Yihao Zhang, president and CEO, China, will retire from the company effective July 1, 2025. Will Song, a Johnson & Johnson veteran for over 20 years, has been named GE HealthCare’s new president and CEO, China, and will join the company on April 1, 2025, ahead of leading the region starting July 1 following Yihao’s departure. Yihao’s planned retirement allowed GE HealthCare to purposefully identify and prepare a qualified successor in Will, an exceptional leader with ...

February 27, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch